A study protocol: a community pharmacy-based intervention for improving the management of sleep disorders in the community settings

Table 2 Summary of measurements and study outcomes

Measurements	Instruments	Group	T0	T1	T2	Outcome
Surveys/measuring tools
Socio-demographic and lifestyle	Questionnaire	ICG, UCG	x				2˚
Health-related quality of life ^I,E	WHO-5 Well-being index (1998)	ICG, UCG	x		x	1˚
Sleep scale scores ^I,E	ESS, ISI, MAPI, IRLSSG	ICG, UCG	x		x	1˚
Community pharmacy survey ^I	Questionnaire	ICG, UCG	x				2˚
Close-out survey ^E	Questionnaire	ICG, UCG			x	1˚	2˚
Sleep parameters assessment
SE%	Actigraph only	ICG		x	x	1˚
TST, NWAK, SOL	Actigraph and sleep	ICG		x	x	1˚
	diary
Other factors that may interrupt sleep	Sleep diary only	ICG		x	x	1˚
Pharmacy survey
Close-out survey for pharmacy	Questionnaire	Pharmacists, pharmacy staff			x		2˚

T0 = baseline, T1 = 1 week after baseline, T2 = 2 weeks after baseline.
ICG: intervention care group; UCG: usual care group.
ESS: Epworth Sleepiness Scale; ISI: Insomnia Severity Index; MAPI: Multivariate Apnea Prediction Index; IRLSSG: International Restless Legs Syndrome Study Group.
SE%: Percentage of sleep efficiency; TST: Total sleep time per-24 hour period; NWAK: Number of nocturnal awakenings; SOL: Sleep onset latency.
1˚: Primary outcome; 2˚: Secondary outcome.
I: ‘Initial Pharmacy Visit’ Questionnaires; E: ‘End of Study’ Questionnaires.

ISSN: 1472-6963